Reduced expression and functional impairment of Toll-like receptor 2 on dendritic cells in chronic hepatitis C virus infection.
暂无分享,去创建一个
N. Hayashi | A. Kasahara | N. Hiramatsu | N. Kuzushita | T. Takehara | T. Kanto | M. Sakakibara | T. Yakushijin | T. Oze | M. Inoue | H. Miyatake | I. Itose | M. Miyazaki
[1] S. Esnault,et al. Toll-like receptor 2 expression on human conjunctival epithelial cells: a pathway for Staphylococcus aureus involvement in chronic ocular proinflammatory responses. , 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[2] R. Modlin,et al. Cutting Edge: All-trans Retinoic Acid Down-Regulates TLR2 Expression and Function1 , 2005, The Journal of Immunology.
[3] L. Joosten,et al. Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma. , 2004, Arthritis and rheumatism.
[4] D. Golenbock,et al. Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. , 2004, Gastroenterology.
[5] D. Lu,et al. Human Immunodeficiency Virus Type 1 Protease Inhibitors Block Toll-Like Receptor 2 (TLR2)- and TLR4-Induced NF-κB Activation , 2004, Antimicrobial Agents and Chemotherapy.
[6] P. Martiat,et al. Poly(I:C) used for human dendritic cell maturation preserves their ability to secondarily secrete bioactive IL-12. , 2004, International immunology.
[7] S. Akira,et al. Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.
[8] R. Bontrop,et al. Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment , 2003, Hepatology.
[9] T. Ichim,et al. Immune Modulation by Silencing IL-12 Production in Dendritic Cells Using Small Interfering RNA12 , 2003, The Journal of Immunology.
[10] L. Romics,et al. Hepatitis C Virus Core and Nonstructural Protein 3 Proteins Induce Pro- and Anti-inflammatory Cytokines and Inhibit Dendritic Cell Differentiation1 , 2003, The Journal of Immunology.
[11] M. Lotze,et al. Differential effects of IL‐12 on the generation of alloreactive CTL mediated by murine and human dendritic cells: a critical role for nitric oxide , 2003, Journal of leukocyte biology.
[12] N. Bhardwaj,et al. A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy. , 2002, Vaccine.
[13] J. Hoofnagle,et al. Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection1 , 2002, The Journal of Immunology.
[14] S. Akira,et al. Interferon-α and Interleukin-12 Are Induced Differentially by Toll-like Receptor 7 Ligands in Human Blood Dendritic Cell Subsets , 2002, The Journal of experimental medicine.
[15] A. Bohbot,et al. Dendritic cell susceptibility to hepatitis C virus genotype 1 infection , 2002, Journal of medical virology.
[16] Bali Pulendran,et al. Lipopolysaccharides from Distinct Pathogens Induce Different Classes of Immune Responses In Vivo1 , 2001, The Journal of Immunology.
[17] Antonio Lanzavecchia,et al. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells , 2001, European journal of immunology.
[18] F. Re,et al. Toll-like Receptor 2 (TLR2) and TLR4 Differentially Activate Human Dendritic Cells* , 2001, The Journal of Biological Chemistry.
[19] N. Kadowaki,et al. Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens , 2001, The Journal of experimental medicine.
[20] V. Hornung,et al. Identification of CpG oligonucleotide sequences with high induction of IFN‐α/β in plasmacytoid dendritic cells , 2001 .
[21] Giampiero Girolomoni,et al. Regulatory Activity of Autocrine IL-10 on Dendritic Cell Functions1 , 2001, The Journal of Immunology.
[22] N. Kadowaki,et al. Distinct CpG DNA and Polyinosinic-Polycytidylic Acid Double-Stranded RNA, Respectively, Stimulate CD11c− Type 2 Dendritic Cell Precursors and CD11c+ Dendritic Cells to Produce Type I IFN1 , 2001, The Journal of Immunology.
[23] F. Zoulim,et al. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. , 2001, Gastroenterology.
[24] P. Godowski,et al. Activation of Toll-Like Receptor 2 on Human Dendritic Cells Triggers Induction of IL-12, But Not IL-101 , 2000, The Journal of Immunology.
[25] A. Aderem,et al. Toll-like receptors in the induction of the innate immune response , 2000, Nature.
[26] R. Verdijk,et al. Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. , 1999, Journal of immunology.
[27] N. Hayashi,et al. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. , 1999, Journal of immunology.
[28] Hanno Langen,et al. Maturation, Activation, and Protection of Dendritic Cells Induced by Double-stranded RNA , 1999, The Journal of experimental medicine.
[29] D. Hart,et al. Dendritic cells: unique leukocyte populations which control the primary immune response. , 1997, Blood.
[30] C. Rice,et al. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients , 1996, Journal of virology.
[31] M. Massari,et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. , 1996, The Journal of clinical investigation.
[32] E. Yunis,et al. Predictability of alloreactivity among unrelated individuals: role for HLA-DPB1. , 1995, Tissue antigens.
[33] C. Ferrari,et al. T‐cell response to structural and nonstructural hepatitis C virus antigens in persistent and self‐limited hepatitis C virus infections , 1994, Hepatology.
[34] R. Steinman,et al. The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro. , 1992, The Journal of clinical investigation.
[35] R. Purcell,et al. Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus , 1990, Hepatology.
[36] C. Guidos,et al. Functional differences and complementation between dendritic cells and macrophages in T-cell activation. , 1987, Immunology.
[37] M. Witmer,et al. Dendritic cells are the principal stimulators of the primary mixed leukocyte reaction in mice , 1983, The Journal of experimental medicine.